Nul

Nul, a British health tech startup focused on an alcohol reduction platform, has successfully closed a seed funding round, securing £730,000 (equivalent to $1 million). The investment was led by DMG Ventures, the venture arm of Daily Mail and General Trust (DMGT), with additional participation from BYVP and angel investors.

Summary of transaction details:

• Value: £730,000
• Sector: Health Tech, Digital Health, Alcohol Reduction Platform
• Advisor: Not specified
• Key Entities: Target: Nul; Lead Investor: DMG Ventures; Other Investors: BYVP, Angel backers
• Location: UK (Nul is a British startup)

Note: This seed funding round will enable Nul to proceed with its full commercial launch and team expansion, aiming to modernize alcohol reduction services through an accessible, discreet, and evidence-based digital health platform. The investment by DMG Ventures underscores a strategic alignment with the increasing demand for innovative solutions in public health and wellness.